WHO ICTRP trial
Phase II trial testing Ablative radiotherapy in metastatic prostate cancer…
EUCTR2016-005284-13-IT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2016-005284-13-IT |
|---|---|
| Public title | Phase II trial testing Ablative radiotherapy in metastatic prostate cancer, resistant to hormonal therapy and with number of metastatic lesions lower or equal to three. |
| Scientific title | A 2 arm, phase II controlled randomized trial comparing efficacy and safety of abiraterone and abiraterone associated with Ablative Radiation Therapy in patients with Oligometastatic castration resistant prostate cancer (ARTO trial) - ARTO |
| Primary sponsor | DIPARTIMENTO DI SCIENZE BIOMEDICHE SPERIMENTALI E CLINICHE, UNIVERSITà DI FIRENZE |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Italy |
| Conditions | Oligometastatic prostate cancer, castration resistant MedDRA version: 21.1 Level: PT Classification code 10062904 Term: Hormone-refractory prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl… |
| Interventions | Trade Name: ZYTIGA - 250 MG - COMPRESSA - USO ORALE - FLACONE 120 COMPRESSE Product Name: Zytiga Product Code: [41427016] Pharmaceutical Form: Tablet INN or Proposed INN: abiraterone acetato CAS Number: 154229-18-2 Current Sponsor code… |
| Registration date | Sep 2, 2021 |
| Target size | 174 |
| Secondary IDs | ARTO |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: